Insulin resistance, oxidative stress and aspirin: therapeutic implications?
Quilley
John
J
D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000188:drug therapy / Q000517:prevention & control*; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy / Q000517:prevention & control*; D007333:Insulin Resistance / Q000502:physiology*; D018384:Oxidative Stress / Q000187:drug effects*; D013997:Time Factors
D016861:Cyclooxygenase Inhibitors; D005947:Glucose; D001241:Aspirin